A citation-based method for searching scientific literature

Cindy Shin-Yi Lin, Arun V Krishnan, Susanna B Park, Matthew C Kiernan. Arch Neurol 2011
Times Cited: 42







List of co-cited articles
393 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multiple measures of axonal excitability: a new approach in clinical testing.
M C Kiernan, D Burke, K V Andersen, H Bostock. Muscle Nerve 2000
338
33


Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
Richard A C Hughes, Peter Donofrio, Vera Bril, Marinos C Dalakas, Chunqin Deng, Kim Hanna, Hans-Peter Hartung, Norman Latov, Ingemar S J Merkies, Pieter A van Doorn. Lancet Neurol 2008
432
28

Axonal ion channels from bench to bedside: a translational neuroscience perspective.
Arun V Krishnan, Cindy S-Y Lin, Susanna B Park, Matthew C Kiernan. Prog Neurobiol 2009
132
28


Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish.
Matthew C Kiernan, Geoffrey K Isbister, Cindy S-Y Lin, David Burke, Hugh Bostock. Ann Neurol 2005
133
26

The voltage dependence of I(h) in human myelinated axons.
James Howells, Louise Trevillion, Hugh Bostock, David Burke. J Physiol 2012
108
23

CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology.
John D Pollard, Patricia J Armati. J Peripher Nerv Syst 2011
44
23

Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles.
Jia-Ying Sung, Satoshi Kuwabara, Ryuji Kaji, Kazue Ogawara, Masahiro Mori, Kazuaki Kanai, Hiroyuki Nodera, Takamichi Hattori, Hugh Bostock. Muscle Nerve 2004
49
23

Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Delphine Boërio, Alain Créange, Jean-Yves Hogrel, Antoine Guéguen, Dominique Bertrand, Jean-Pascal Lefaucheur. J Neurol Sci 2010
21
47

Threshold tracking techniques in the study of human peripheral nerve.
H Bostock, K Cikurel, D Burke. Muscle Nerve 1998
405
19

Electrophysiologic correlations with clinical outcomes in CIDP.
Vera Bril, Marta Banach, Marinos C Dalakas, Chunqin Deng, Peter Donofrio, Kim Hanna, Hans-Peter Hartung, Richard A C Hughes, Hans Katzberg, Norman Latov,[...]. Muscle Nerve 2010
48
19




Membrane properties in chronic inflammatory demyelinating polyneuropathy.
C Cappelen-Smith, S Kuwabara, C S Lin, I Mogyoros, D Burke. Brain 2001
65
16

Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block.
Matthew C Kiernan, Jean-Marc Guglielmi, Ryuji Kaji, Nicholas M F Murray, Hugh Bostock. Brain 2002
138
14

Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features.
E A Cats, B C Jacobs, N Yuki, A P Tio-Gillen, S Piepers, H Franssen, J-T van Asseldonk, L H van den Berg, W-L van der Pol. Neurology 2010
83
14


Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy.
C Cappelen-Smith, S Kuwabara, C S Lin, I Mogyoros, D Burke. Ann Neurol 2000
67
14


A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
Siraj A Misbah, Andreas Baumann, Raffaella Fazio, Patrizia Dacci, Dirk S Schmidt, Janet Burton, Matthias Sturzenegger. J Peripher Nerv Syst 2011
62
14

Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy.
Krista Kuitwaard, Pieter A van Doorn, Marinus Vermeulen, Leonard H van den Berg, Esther Brusse, Anneke J van der Kooi, W-Ludo van der Pol, Ivo N van Schaik, Nicolette Notermans, Anne P Tio-Gillen,[...]. J Neurol Neurosurg Psychiatry 2013
52
14

Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.
Susan E Tomlinson, S Veronica Tan, Dimitri M Kullmann, Robert C Griggs, David Burke, Michael G Hanna, Hugh Bostock. Brain 2010
73
14


IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN.
Sanne Piepers, Marc D Jansen, Elisabeth A Cats, Nina M van Sorge, Leonard H van den Berg, W-Ludo van der Pol. J Neuroimmunol 2010
43
11

Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.
Susanna B Park, David Goldstein, Cindy S-Y Lin, Arun V Krishnan, Michael L Friedlander, Matthew C Kiernan. J Clin Oncol 2009
115
11

Strength-duration properties of human peripheral nerve.
I Mogyoros, M C Kiernan, D Burke. Brain 1996
262
11


Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
Krista Kuitwaard, Jenny de Gelder, Anne P Tio-Gillen, Wim C J Hop, Teun van Gelder, Albert W van Toorenenbergen, Pieter A van Doorn, Bart C Jacobs. Ann Neurol 2009
124
11

Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report.
Patrizia Dacci, Nilo Riva, Marina Scarlato, Irmgard Andresen, Dirksteffen Schmidt, Giancarlo Comi, Raffaella Fazio. Neurol Sci 2010
30
16

Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.
L H Markvardsen, J-C Debost, T Harbo, S H Sindrup, H Andersen, I Christiansen, M Otto, N K Olsen, L L Lassen, J Jakobsen. Eur J Neurol 2013
99
11

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
S I van Nes, E K Vanhoutte, P A van Doorn, M Hermans, M Bakkers, K Kuitwaard, C G Faber, I S J Merkies. Neurology 2011
196
11

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Norman Latov, Chunqin Deng, Marinos C Dalakas, Vera Bril, Peter Donofrio, Kim Hanna, Hans-Peter Hartung, Richard A C Hughes, Ingemar S J Merkies, Peter A van Doorn. Arch Neurol 2010
75
11



Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes.
Satoshi Kuwabara, Kazue Ogawara, Jia-Ying Sung, Masahiro Mori, Kazuaki Kanai, Takamichi Hattori, Nobuhiro Yuki, Cindy S-Y Lin, David Burke, Hugh Bostock. Ann Neurol 2002
87
11


Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.
Filip Eftimov, Marinus Vermeulen, Rob J de Haan, Leonard H van den Berg, Ivo N van Schaik. J Peripher Nerv Syst 2009
87
11


Metabolism of immunoglobulins.
T A Waldmann, W Strober. Prog Allergy 1969
768
11

Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy.
Thomas Harbo, Henning Andersen, Johannes Jakobsen. Neurology 2010
66
11


Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability.
Matthew C Kiernan, Arun V Krishnan, Cindy S-Y Lin, David Burke, Samuel F Berkovic. Brain 2005
50
11

Motor axon excitability during Wallerian degeneration.
Mihai Moldovan, Susana Alvarez, Christian Krarup. Brain 2009
59
11

IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy.
N Yuki, H Watanabe, T Nakajima, P J Späth. J Neurol Neurosurg Psychiatry 2011
73
9


Assessment of nerve excitability in toxic and metabolic neuropathies.
Arun V Krishnan, Cindy S-Y Lin, Susanna B Park, Matthew C Kiernan. J Peripher Nerv Syst 2008
52
9

Altered motor nerve excitability in end-stage kidney disease.
Arun V Krishnan, Richard K S Phoon, Bruce A Pussell, John A Charlesworth, Hugh Bostock, Matthew C Kiernan. Brain 2005
83
9

Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia.
Matthew C Kiernan, R Jon L Walters, Kjeld V Andersen, David Taube, Nicholas M F Murray, Hugh Bostock. Brain 2002
107
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.